Saturday, April 19, 2025
71.7 F
Peshawar

Where Information Sparks Brilliance

HomeWorldNovartis in the lead to acquire cancer drug developer MorphoSys  | Reuters...

Novartis in the lead to acquire cancer drug developer MorphoSys  | Reuters News Agency


Business & Finance

Reuters exclusively reported that drug maker Novartis AG (NOVN.S) is in advanced talks to acquire MorphoSys AG (MORG.DE), a developer of cancer treatments that has a market value of 1.6 billion euros ($1.7 billion). 

Market Impact

MorphoSys shares rose more than 40% on the news. 

Article Tags

Topics of Interest: Business & Finance

Type: Reuters Best

Sectors: Pharmaceuticals & Healthcare

Regions: Europe

Win Types: Exclusivity

Story Types: Exclusive / Scoop

Media Types: Text

Customer Impact: Significant National Story



Source link

RELATED ARTICLES

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Most Popular

 

Recent Comments